The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global pharmaceutical filtration market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Pharmaceutical filtration refers to the process of separating solid particulate matter from fluids and gases using a porous medium. It can be performed using different methods depending on the application and chemical solution. For instance, ultrafiltration (UF) is a pressure-driven barrier that suspends pathogens and generates a high purity level in products. It is widely utilized in the separation, concentration, and purification of specific macromolecules and the production of vaccines, plasma, and serums. Moreover, cross-flow filtration is recently developed for eliminating total dissolved solids (TDS) in water.
A considerable rise in the prevalence of chronic diseases has escalated the demand for generic medicines worldwide. This, along with stringent regulations for quality control of drugs, represents one of the key factors impelling the growth of the market. Moreover, the rising number of drug launches is positively influencing the adoption of pharmaceutical filtration methods to remove potential pathogens during the manufacturing processes. Technological advancements in the production of large molecules and biologics are also bolstering the market growth. Apart from this, the rising demand for advanced therapeutic drugs and increasing investments in research and development (R&D) projects are other factors contributing to market growth. Furthermore, the leading companies are focusing on collaborations, partnerships and merger and acquisitions (M&A) activities. This will assist these companies in developing innovative products that can be used across various applications, such as bioburden testing, virus inactivation, and buffer preparation.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical filtration market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, technique, application and scale of operation.
Breakup by Product:
Breakup by Technique:
Breakup by Application:
Breakup by Scale of Operation:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Amazon Filters Ltd, Danaher Corporation, Eaton Corporation plc, General Electric Company, Graver Technologies LLC, Meissner Filtration Products Inc, Merck KGaA, Parker Hannifin Corporation and Sartorius AG.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Technique, Application, Scale of Operation, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3M Company, Amazon Filters Ltd, Danaher Corporation, Eaton Corporation plc, General Electric Company, Graver Technologies LLC, Meissner Filtration Products Inc, Merck KGaA, Parker Hannifin Corporation and Sartorius AG.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at